Enhanced Nutraceutical Gel Formulations and Delivery Systems

Publication ID: 24-11857593_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Nutraceutical Gel Formulations and Delivery Systems,” Published Technical Disclosure No. 24-11857593_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857593_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,593.

Summary of the Inventive Concept

The present inventive concept relates to improved nutraceutical gel formulations and delivery systems, addressing limitations of existing gel-based products by providing stronger gel structures, higher viscosity, extended shelf life, and consistent dispensing.

Background and Problem Solved

The original patent disclosed nutraceutical gel products with limitations in terms of gel structure, viscosity, and shelf life. The present inventive concept solves these problems by introducing cross-linked galactomannan and polysaccharide matrices, incorporating additional gelling agents, and integrating antioxidants and preservatives to enhance the overall performance and longevity of the nutraceutical gels.

Detailed Description of the Inventive Concept

The new inventive concept comprises four key aspects: (1) a system featuring a nutraceutical gel with a cross-linked galactomannan and polysaccharide matrix, providing a stronger gel structure; (2) a method for preparing a nutraceutical gel by mixing and heating a galactomannan with a polysaccharide and an immune modulator; (3) a nutraceutical gel composition with a higher viscosity achieved by incorporating additional gelling agents; and (4) a system for delivering a nutraceutical gel with a dispensing mechanism designed to dispense a consistent amount of gel with each use. These enhancements address the limitations of the original patent and provide improved performance, convenience, and user experience.

Novelty and Inventive Step

The new claims introduce the concept of cross-linked matrices, higher viscosity gels, and integrated antioxidant and preservative systems, which are novel and non-obvious compared to the original patent. The inventive step lies in the specific combination and implementation of these features to achieve the enhanced performance and longevity of the nutraceutical gels.

Alternative Embodiments and Variations

Alternative embodiments may include variations in the type and ratio of galactomannan and polysaccharide, different immune modulators, or additional functional ingredients. The dispensing mechanism could be adapted for different container sizes, shapes, or materials, and the antioxidant and preservative systems could be tailored to specific product requirements.

Potential Commercial Applications and Market

The enhanced nutraceutical gel formulations and delivery systems have significant commercial potential in the health supplement industry, particularly in the areas of immune system support and overall wellness. The improved performance, convenience, and user experience offered by these innovations can help manufacturers and distributors differentiate their products and capture a larger market share.

CPC Classifications

SectionClassGroup
A A61 A61K36/889
A A23 A23G4/12
A A23 A23L29/231
A A23 A23L29/238
A A23 A23L29/27
A A23 A23L29/271
A A23 A23L29/284
A A23 A23L33/10
A A23 A23L33/105
A A61 A61K36/185
A A61 A61K36/35
A A61 A61K36/87
A A61 A61K47/36
A A23 A23V2002/00
A A23 A23V2200/324
A A23 A23V2250/21
A A23 A23V2250/21166
A A23 A23V2250/506
A A23 A23V2250/5086
A A23 A23V2250/708
A A61 A61K2300/00

Field of Art

Nutraceutical formulations, specifically gel-based nutritional supplements with immune modulators, involving food science, biochemistry, and pharmaceutical preparation techniques

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in food science, biochemistry, or pharmaceutical sciences, having expertise in gel formulation, polysaccharide interactions, and nutritional supplement development

Obviousness Rationale

A PHOSITA would recognize that the PTD's variations represent predictable engineering improvements to the source patent's gel-based nutraceutical system, utilizing standard techniques of matrix modification, viscosity enhancement, and delivery system optimization that are well-known in the field of functional food and supplement development.

Obvious Combinations & Variations

Source Patent Element
Gel composition using xanthan and guar gum
PTD Variation
Cross-linked galactomannan and polysaccharide matrix with enhanced structural integrity
Obviousness Reasoning
Cross-linking polysaccharide matrices is a known technique for improving gel stability and mechanical properties, representing a predictable variation that a PHOSITA would find obvious for enhancing gel performance
Source Patent Element
Transfer factor dispersed in gel matrix
PTD Variation
Integrated antioxidant and preservative system dispersed throughout gel
Obviousness Reasoning
Adding complementary functional ingredients to nutritional gel matrices is a standard formulation approach, with predictable benefits for product stability and shelf life
Source Patent Element
Oligomeric proanthocyanidin-containing fruit extract
PTD Variation
Higher viscosity gel achieved by incorporating additional gelling agents
Obviousness Reasoning
Modifying gel viscosity through strategic gelling agent selection is a routine design choice for a PHOSITA seeking to optimize texture and dispensing characteristics
Source Patent Element
Nutraceutical gel composition
PTD Variation
Specialized dispensing mechanism for consistent gel delivery
Obviousness Reasoning
Developing precise dispensing systems for viscous nutritional products is a standard engineering solution addressing user convenience and product usability
Source Patent Element
Acai-based nutraceutical product with transfer factor
PTD Variation
Alternative immune modulators and functional ingredient combinations
Obviousness Reasoning
Exploring alternative ingredient combinations within established nutraceutical frameworks represents an expected iterative development process for a skilled practitioner
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857593 and the disclosed technical variations, a person having ordinary skill in the art would find the claimed nutraceutical gel formulations and delivery systems to be obvious modifications of the prior art, lacking inventive step under 35 U.S.C. ยง 103. The systematic improvements in gel matrix structure, viscosity, stability, and dispensing represent predictable engineering variations that would be readily conceived by a skilled artisan seeking to optimize nutraceutical product performance.

Original Patent Information

Patent NumberUS 11,857,593
TitleNutraceutical gels
Assignee(s)4Life Patents, LLC